 |
         
|
The other big story to which all three networks assigned a reporter was the FDA panel on the side-effects of anti-depressant medication. The pills are designed to treat depression but in some cases they exacerbate it instead and lead to suicide. The drugs already have a warning label for teenage patients. The FDA is now likely to add young adults to its advisory.
As usual CBS was most heavily committed to the pharma beat. Sharyl Attkisson covered the distraught testimony at the FDA panel and Armen Keteyian followed up with an Exclusive on another pill. The FDA is being investigated for using fraudulent clinic trials for the new antibiotic Ketek and adding a cover-up of the risks for liver failure. Keteyian's source David Ross claimed he was ordered not to share his warnings with the press by FDA leadership.
You must be logged in to this website to leave a comment. Please click here to log in so you can participate in the discussion.
